Vercise Neural Navigator 5 - Implantable electrical stimulation device management software - ARTG 462219

Access comprehensive regulatory information for Vercise Neural Navigator 5 - Implantable electrical stimulation device management software in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 462219 and sponsored by Boston Scientific Pty Ltd, manufactured by Boston Scientific Neuromodulation Corporation in United States of America. The device registration started on September 12, 2024.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.